Arthritis Prevention In the Pre-clinical Phase of Rheumatoid Arthritis with Abatacept: a randomised controlled trial
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2018
Price : $35 *
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms APIPPRA
- 12 Dec 2018 Status changed from active, no longer recruiting to completed.
- 01 Aug 2016 Planned End Date changed from 31 Dec 2016 to 11 Dec 2018.
- 01 Aug 2016 Status changed from recruiting to active, no longer recruiting.